SCHEMBL6040931

SCHEMBL6040931

C1=NSSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10492094 0.97
Pyrazole SCHEMBL10935796 0.75
SCHEMBL8470044 0.57
SCHEMBL8470046 0.57
SCHEMBL4147511 0.45
SCHEMBL236777 0.45
SCHEMBL5134172 0.40
SCHEMBL43805 0.40
SCHEMBL452580 0.40
SCHEMBL380648 0.38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3658544-B1 DERIVATIVES OF LUCIFERIN AND METHODS FOR THEIR SYNTHESIS UNIV CAPE TOWN (ZA) 2024-07-31 EP claimed
CN-114084877-B Method for obtaining ultrapure ferric phosphate from waste lithium iron phosphate pole piece material and obtained ultrapure ferric phosphate 长沙理工大学 2024-01-16 CN claimed
EP-4008330-A1 COMBINED INHIBITION OF AMINO ACID TRANSPORTERS FOR INHIBITING HUMAN PLASMACYTOID DENDRITIC CELL ACTIVITY DURING AUTOIMMUNITY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-06-08 EP claimed
US-11149034-B2 Derivatives of luciferin and methods for their synthesis UNIVERSITY OF CAPE TOWN (ZA) 2021-10-19 US claimed
US-20200331902-A1 DERIVATIVES OF LUCIFERIN AND METHODS FOR THEIR SYNTHESIS UNIVERSITY OF CAPE TOWN (ZA) 2020-10-22 US claimed
CN-1659154-A Process for the preparation of amine stereoisomers APSINTERM LLC (US) 2005-08-24 CN claimed
EP-3658544-B1 DERIVATIVES OF LUCIFERIN AND METHODS FOR THEIR SYNTHESIS UNIV CAPE TOWN (ZA) 2024-07-31 EP disclosed
CN-112424201-B Protein kinase inhibitors that promote liver regeneration or reduce or prevent hepatocyte death 海帕瑞吉尼克斯股份有限公司 2024-04-02 CN disclosed
CN-117304135-A Synthesis method of 4-substituted-5H-1, 2, 3-dithiazole-5-thione and derivative 衡阳师范学院 2023-12-29 CN disclosed
CN-117157269-A Compounds and their use in the photovoltaic field 浙江光昊光电科技有限公司 2023-12-01 CN disclosed
WO-2022122668-A1 COMBINED INHIBITION OF AMINO ACID TRANSPORTERS FOR INHIBITING HUMAN PLASMACYTOID DENDRITIC CELL ACTIVITY DURING AUTOIMMUNITY MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-06-16 WO disclosed
EP-4008330-A1 COMBINED INHIBITION OF AMINO ACID TRANSPORTERS FOR INHIBITING HUMAN PLASMACYTOID DENDRITIC CELL ACTIVITY DURING AUTOIMMUNITY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-06-08 EP disclosed
CN-114084877-A Method for obtaining ultrapure iron phosphate from waste lithium iron phosphate electrode plate material and obtained ultrapure iron phosphate 长沙理工大学 2022-02-25 CN disclosed
EP-0771527-A1 Antimicrobial compounds with quick speed of kill ROHM AND HAAS COMPANY (US) 1997-05-07 EP disclosed
US-5206253-A DISPHOSPHONIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS BOEHRINGER MANNHEIM, GMBH (DE) 1993-04-27 US disclosed
EP-0056475-A3 PHARMACEUTICAL COMPOSITIONS MERCK PATENT GmbH (DE) 1982-08-25 EP disclosed
EP-0056475-A2 Pharmaceutical compositions MERCK PATENT GmbH (DE) 1982-07-28 EP disclosed
EP-0056475-A2 Pharmaceutical compositions MERCK PATENT GmbH (DE) 1982-07-28 EP disclosed
US-4220764-A Preparation of tertiary heterocyclic amines UOP INC. (US) 1980-09-02 US disclosed
US-4179469-A Preparation of amines UOP INC. (US) 1979-12-18 US disclosed